登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《JAMA，3月26日，Turbulent Gas Clouds and Respiratory Pathogen Emissions》

  • 来源专题：COVID-19科研动态监测
  • 编译者： zhangmin
  • 发布时间：2020-03-27

  • Turbulent Gas Clouds and Respiratory Pathogen Emissions

    Potential Implications for Reducing Transmission of COVID-19

    Lydia Bourouiba, PhD1

    Author Affiliations Article Information

    JAMA. Published online March 26, 2020. doi:10.1001/jama.2020.4756

    The current coronavirus disease 2019 (COVID-19) outbreak vividly demonstrates the burden that respiratory infectious diseases impose in an intimately connected world. Unprecedented containment and mitigation policies have been implemented in an effort to limit the spread of COVID-19, including travel restrictions, screening and testing of travelers, isolation and quarantine, and school closures.

  • 原文来源：https://jamanetwork.com/journals/jama/fullarticle/2763852?resultClick=1
7浏览量
原文链接
相关报告

  • 《JAMA，3月26日，Can SARS-CoV-2 Infection Be Acquired In Utero?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-27
    • Can SARS-CoV-2 Infection Be Acquired In Utero? More Definitive Evidence Is Needed David W. Kimberlin, MD1; Sergio Stagno, MD1 Author Affiliations Article Information JAMA. Published online March 26, 2020. doi:10.1001/jama.2020.4868 Two articles reported in this issue of JAMA from separate research teams in China present details of 3 neonates who may have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in utero from mothers with coronavirus disease 2019 (COVID-19).1,2 Evidence for such transmission is based on elevated IgM antibody values in blood drawn from the neonates following birth. All infants also had elevated IgG antibody values and cytokine levels, although these may have crossed the placenta from the mother to the infant. No infant specimen had a positive reverse transcriptase–polymerase chain reaction test result, so there is not virologic evidence for congenital infection in these cases to support the serologic suggestion of in utero transmission. Nevertheless, the serologic data are provocative for a virus that is believed to be spread by respiratory secretions and—given the modeling showing that a significant percentage of the world’s population, many of them pregnant women, will be infected over the next weeks or months—it is one that deserves careful consideration. However, at this time, these data are not conclusive and do not prove in utero transmission.
    51浏览量
    原文链接

  • 《JAMA，3月9日，Diagnostic Testing for the Novel Coronavirus》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-11
    • Diagnostic Testing for the Novel Coronavirus Joshua M. Sharfstein, MD1; Scott J. Becker, MS2; Michelle M. Mello, JD, PhD3 Author Affiliations Article Information JAMA. Published online March 9, 2020. doi:10.1001/jama.2020.3864 Controversies over diagnostic testing have dominated US headlines about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for coronavirus disease 2019 (COVID-19). Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks of the epidemic. The CDC also initially limited access to testing to a narrow group of individuals with known exposure. The delayed discovery of a case of COVID-19 in California, followed quickly by evidence of community transmission in multiple states, revealed the shortcomings of this strategy. In the early stages, COVID-19 has spread beyond the nation’s ability to detect it.
    84浏览量
    原文链接